Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Fluence’s Elizabeth Nielson on Professional Education for the Psychedelics Field

Fluence’s Elizabeth Nielson on Professional Education for the Psychedelics Field

  • Post published:March 19, 2024
  • Post category:Interviews/Pα+
Read more about the article Bay Staters for Natural Medicine Co-Founder, James Davis, on Grassroots Psychedelic Policy Reform, a Community-based Facilitator Network, and the Corporatisation of Psychedelics

Bay Staters for Natural Medicine Co-Founder, James Davis, on Grassroots Psychedelic Policy Reform, a Community-based Facilitator Network, and the Corporatisation of Psychedelics

  • Post published:March 8, 2024
  • Post category:Interviews
Read more about the article A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and Promise of Medicinal Psychedelics”

A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and Promise of Medicinal Psychedelics”

  • Post published:February 1, 2024
  • Post category:Interviews
Read more about the article Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

  • Post published:January 31, 2024
  • Post category:Interviews/Pα+
Read more about the article Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics

Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics

  • Post published:November 20, 2023
  • Post category:Interviews/Pα+
Read more about the article Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research

Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research

  • Post published:November 20, 2023
  • Post category:Interviews/Pα+

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More